Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Arch Pharm Res ; 43(6): 646-654, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32533502

RESUMEN

The purpose of this study was to investigate the protective effects of fucoidan on Lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. The mice were divided into the control, LPS, and LPS + fucoidan (20, 40, or 80 mg/kg) groups. LPS was given by intracheal instillation and fucoidan was given 1 h before LPS treatment. Myeloperoxidase (MPO) activity, malondialdehyde (MDA), superoxide dismutase (SOD), reactive oxygen species (ROS), glutathione (GSH) contents, and inflammatory cytokine production were detected. The results showed that LPS-induced TNF-α, IL-1ß, and IL-6 production, lung wet/dry (W/D) ratio, ROS, MDA content, and MPO activity were suppressed by fucoidan. The levels of SOD and GSH were increased by fucoidan. Meanwhile, LPS-induced nuclear factor kappa-B (NF-κB) activation was dose-dependently attenuated by fucoidan. Furthermore, fucoidan increased the expression of nuclear factor erythroid-2 related factor 2 (Nrf2), Glycogen synthase kinase3ß (GSK-3ß), and heme oxygenase (HO-1). In vitro, the results demonstrated that fucoidan or GSK-3ß inhibitor significantly inhibited LPS-induced TNF-α production in A549 cells. And the inhibition of fucoidan on TNF-α production was blocked by Nrf2 siRNA. This study showed fucoidan protected mice against LPS-induced ALI through inhibiting inflammatory and oxidative responses via regulating GSK-3ß-Nrf2 signaling pathway.


Asunto(s)
Lesión Pulmonar Aguda/tratamiento farmacológico , Lipopolisacáridos/antagonistas & inhibidores , Polisacáridos/farmacología , Transducción de Señal/efectos de los fármacos , Células A549 , Lesión Pulmonar Aguda/inducido químicamente , Lesión Pulmonar Aguda/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Glucógeno Sintasa Quinasa 3 beta/antagonistas & inhibidores , Glucógeno Sintasa Quinasa 3 beta/biosíntesis , Humanos , Intubación Intratraqueal , Lipopolisacáridos/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Factor 2 Relacionado con NF-E2/biosíntesis , Polisacáridos/administración & dosificación
2.
Can J Physiol Pharmacol ; 97(5): 345-351, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-29894643

RESUMEN

We aimed to investigate whether the cardioprotection of sevoflurane against ischemia-reperfusion (IR) injury is via inhibiting endoplasmic reticulum stress. The rat in vivo model of myocardial IR injury was induced by ligation of the left anterior descending coronary artery. Sevoflurane significantly ameliorated the reduced cardiac function, increased infarct size, and elevated troponin I level and lactate dehydrogenase activity in plasma induced by IR injury. Sevoflurane suppressed the IR-induced myocardial apoptosis. The increased protein levels of glucose-regulated protein 78 and C/EBP homologous protein (CHOP) after myocardial IR were significantly reduced by sevoflurane. The protein levels of phosphorylated protein kinase RNA-like endoplasmic reticulum kinase (PERK), phosphorylated eukaryotic initiation factor 2 (eIF2α), and activating transcription factor 4 (ATF4) were significantly increased in rats with IR and attenuated by sevoflurane treatment. The phosphorylation of Akt was further activated by sevoflurane. The cardioprotection of sevoflurane could be blocked by wortmannin, a PI3K/Akt inhibitor. Our results suggest that the cardioprotection of sevoflurane against IR injury might be mediated by suppressing PERK/eIF2a/ATF4/CHOP signaling via activating the Akt pathway, which helps in understanding the novel mechanism of the cardioprotection of sevoflurane.


Asunto(s)
Cardiotónicos/farmacología , Estrés del Retículo Endoplásmico/efectos de los fármacos , Daño por Reperfusión Miocárdica/patología , Daño por Reperfusión Miocárdica/prevención & control , Sevoflurano/farmacología , Factor de Transcripción Activador 4/metabolismo , Animales , Apoptosis/efectos de los fármacos , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/patología , Factor 2 Eucariótico de Iniciación/metabolismo , Corazón/efectos de los fármacos , Corazón/fisiopatología , Masculino , Daño por Reperfusión Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/fisiopatología , Miocardio/metabolismo , Miocardio/patología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , eIF-2 Quinasa/metabolismo
3.
Guang Pu Xue Yu Guang Pu Fen Xi ; 25(10): 1595-8, 2005 Oct.
Artículo en Chino | MEDLINE | ID: mdl-16395891

RESUMEN

The chemical functionalization process of carbon nanotubes(CNTs) by hydrothermal treatments was investigated systematically under various reaction conditions, including different reagents, treatment time, and temperature. The treated samples were characterized by the FTIR, XPS and Raman spectroscopy. The results revealed that the hydrothermal technology is an effective method for the functionalization of CNTs and the control of the resulting chemical groups.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...